EUVIMEDEUVIMED entdecken
Crossref

Cleaving Folded RNA with DNAzyme Agents

Daria D Nedorezova, Mikhail V Dubovichenko, Arseniy J Kalnin, Moustapha A Y Nour, Ahmed A Eldeeb, Anna I Ashmarova, Gabdulla F Kurbanov, Dmitry M Kolpashchikov iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202300637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Daria D Nedorezova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of molecular robotics and biosensor systems, Laboratory of Frontier nucleic acid technologies in gene therapy of cancer, SCAMT Institute, …. Hauptthemen laut MEDLINE: RNA, DNA, Catalytic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: ITMO University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cleavage of biological mRNA by DNAzymes (Dz) has been proposed as a variation of oligonucleotide gene therapy (OGT). The design of Dz‐based OGT agents includes computational prediction of two RNA‐binding arms with low affinity (melting temperatures (T m ) close to the reaction temperature of 37 °C) to avoid product inhibition and maintain high specificity. However, RNA cleavage might be limited by the RNA binding step especially if the RNA is folded in secondary structures. This calls for the need for two high‐affinity RNA‐binding arms. In this study, we optimized 10–23 Dz‐based OGT agents for cleavage of three RNA targets with different folding energies under multiple turnover conditions in 2 mM Mg 2+ at 37 °C. Unexpectedly, one optimized Dz had each RNA‐binding arm with a T m ≥60 °C, without suffering from product inhibition or low selectivity. This phenomenon was explained by the folding of the RNA cleavage products into stable secondary structures. This result suggests that Dz with long (high affinity) RNA‐binding arms should not be excluded from the candidate pool for OGT agents. Rather, analysis of the cleavage products’ folding should be included in Dz selection algorithms. The Dz optimization workflow should include testing with folded rather than linear RNA substrates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNADNA, CatalyticRNA, MessengerOligonucleotides

Stichwörter der Autor:innen

DNAzymes kineticsaffinity/specificity dilemmabinding folded RNAselectivity of RNA recognition

Substanzen

RNADNA, CatalyticRNA, MessengerOligonucleotides

Autor:innen und Institutionen

  • Laboratory of molecular robotics and biosensor systems, Laboratory of Frontier nucleic acid technologies in gene therapy of cancer, SCAMT Institute, ITMO University, St. Petersburg, 191002, Russian Federation.
  • Chemistry Department, University of Central Florida, Orlando, FL 32816-2366, USA.
  • Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USA.

ORCID-Profile: Dmitry M Kolpashchikov

Förderung

  • ITMO University

Zitieren

APA

Nedorezova, D. D., Dubovichenko, M. V., Kalnin, A. J., Nour, M. A. Y., Eldeeb, A. A., Ashmarova, A. I., Kurbanov, G. F., & Kolpashchikov, D. M. (2024). Cleaving Folded RNA with DNAzyme Agents. ChemBioChem. https://doi.org/10.1002/cbic.202300637

Vancouver

Nedorezova DD, Dubovichenko MV, Kalnin AJ, Nour MAY, Eldeeb AA, Ashmarova AI, et al. Cleaving Folded RNA with DNAzyme Agents. ChemBioChem. 2024. doi:10.1002/cbic.202300637

BibTeX
@article{Nedorezova2024,
  author = {Nedorezova, Daria D and Dubovichenko, Mikhail V and Kalnin, Arseniy J and Nour, Moustapha A Y and Eldeeb, Ahmed A and Ashmarova, Anna I and Kurbanov, Gabdulla F and Kolpashchikov, Dmitry M},
  title = {Cleaving Folded RNA with DNAzyme Agents},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202300637}
}
Kostenlos starten →